Sanofi names Prof Bassler to board
This article was originally published in Scrip
Executive Summary
Sanofi has nominated Professor Bonnie L Basslerto an independent member of its board of directors. Professor Bassler, 52, is a Howard Hughes Medical Institute investigator, the Squibb Professor in molecular biology, and the chair of the department of molecular biology at Princeton University, New Jersey. Furthermore, Professor Bassler was appointed a member of the US National Science Board by President Barack Obama in 2011. She also serves on oversight, grant, fellowship and award panels for organizations including the National Academies of Sciences, US National Institutes of Health, US National Science Foundation, American Society for Microbiology, Keck Foundation, Burroughs Wellcome Trust, Jane Coffin Childs Fund, PEW Charitable Trust, Gordon and Betty Moore Foundation, and the MIT Whitehead Institute.
You may also be interested in...
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.
Podcast: NodThera On The Role Of The Brain In Driving Chronic Disease
Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, talks to In Vivo about the company’s pipeline and recent data publication in the field of obesity.
Deals Of The Year 2023 Winners Revealed
For In Vivo's 16th annual Deals of the Year contest, we selected 12 nominees in three categories – Top Alliance, Top Financing and Top M&A. The polls are closed, and it is time to reveal the winners.